Corvus Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
CRVS
CUSIP
221015100
Type
Equity
Class
COM
Num filers
48
Total reported value, excl. options
$50.2M
Manager Report Date Value ($000) Shares Option Type